RESUMEN
The perovskite structure of manganate yields a series of intriguing physical properties. Based on the results of first-principles calculations, strontium manganate appears to undergo a magnetic phase transition and a metal-insulator transition-from antiferromagnetic insulator to ferromagnetic metal and then to ferromagnetic insulator-under isotropic volume expansion combined with oxygen octahedral distortions. Interestingly, the results show that increasing the Mn-O bond length and adding rotation of the oxygen octahedra can soften the breathing distortion and account for the insulator phase. We further build a simple model to explain such transitions. Due to electron transfer and the favoring of a hole state of ligandporbitals, the electron state transfer from2(t2g3)to2(eg1+t2g2)and then tot2g3eg1+(t2g3L̲1). Such rearrangement of charges is responsible for the transitions of its magnetic order and electronic structure. Furthermore, we calculate spin susceptibility under the bare conditions and random phase approximation. The magnetic order of the intermediate metal state of itinerant electrons behaves as a ferromagnetic.
RESUMEN
Combination therapy which enhances efficacy and reduces toxicity, has been increasingly applied as a promising strategy for cancer therapy. Here, a reactive oxygen species (ROS) that enhanced combination chemotherapy nanodevices was fabricated based on the Fe-chelated polydopamine (PDA) nanoparticles (NPs). The structure was characterized by dynamic light scattering-autosizer, transmission electron microscopy, energy dispersive spectroscopy, and Fourier-transform infrared (FT-IR) spectrophotometer. The in vitro drug release profile triggered by low intracellular pH indicated that the system demonstrated controlled therapeutic activity. In vitro cell uptake studies showed that doxorubicin (DOX)-loaded Fe-PDA/ folic acid (FA)- polyethylene glycol (DOX@Fe-PDA/FA-PEG) had a strong uptake capacity and can be rapidly internalized by MCF-7 cells. The in vitro experiments demonstrated that DOX@Fe-PDA/FA-PEG triggered the intracellular ROS overproduction, thereby enhancing its therapeutic effect on breast cancer. In summary, this experiment demonstrated the novel DOX-loaded composite NPs used as a potential targeted nanocarrier for breast cancer treatment, which could be a promising therapeutic strategy against breast cancer.